A NEW in-home Eligard
(leuprorelin acetate) injections
service for advanced prostate
cancer will need pharmacy
involvement in supplying the
patient with their Eligard ahead
of the nurse visits and providing
an essential level of support to
men with prostate cancer in the
community.
“Eligard NurseCARE program
is unique in Australia and was
designed to integrate with existing
treatment plans to simplify
patients’ journey of care,” said
Dieter Torheiden, general manager
of Tolmar.
“The service offers 24-hour
telephone support for patients
and regular reporting back to the
supervising clinician.
“It is one of several important
initiatives we are pleased to be able
to provide,” he added.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 14
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.